Japan’s No.1 in cardiovascular sales
We have the largest market share in the products for PCI (percutaneous coronary intervention), minimally invasive treatments for myocardial infarction and angina pectoris in Japan.
*(Source) WIN Partners
Financial summary.
WIN-Partners group aims for higher growth, by expanding sales network and customer base as well as expanding treatment areas and products.
NEWSNews Release
2024.03.28 | Notice Regarding the important personnel change |
---|---|
2024.02.07 | Consolidated Financial Results(Nine Months Ended December 31, 2023) |
2024.02.07 | 3Q presentation slides |
2023.12.22 | Corporate Governance Report has been updated (Japanese site) |
2023.11.28 | 2Q presentation slides |